Department of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
Children's Healthcare of Atlanta, Atlanta, Georgia 30322, United States.
ACS Nano. 2023 Sep 12;17(17):17436-17450. doi: 10.1021/acsnano.3c05508. Epub 2023 Aug 17.
Despite extensive efforts, the principal sites of productive HIV-1 entry in different target cells─plasma membrane (PM) vs endosomes─remain controversial. To delineate the site(s) of HIV-1 fusion, we implemented a triple labeling approach that involves tagging pseudoviruses with the fluid-phase viral content marker, iCherry, the viral membrane marker, DiD, and the extraviral pH sensor, ecliptic pHluorin. The viral content marker iCherry is released into the cytoplasm upon virus-cell fusion irrespective of the sites of fusion. In contrast, the extent of dilution of the membrane marker upon fusion with the PM (loss of signal) vs the endosomal membrane (no change in punctate DiD appearance) discriminates between the principal sites of viral fusion. Additionally, ecliptic pHluorin incorporated into the viral membrane reports whether virus fusion occurs in acidic endosomes. Real-time single virus imaging in living HeLa-derived cells, a CD4+ T-cell line, and activated primary human CD4+ T-cells revealed a strong (80-90%) HIV-1 preference for fusion with endosomes. Intriguingly, we observed HIV-1 fusion only with pH-neutral intracellular vesicles and never with acidified endosomes. These endocytic fusion events are likely culminating in productive infection since endocytic inhibitors, such as EIPA, Pitstop2, and Dynasore, as well as a dominant-negative dynamin-2 mutant, inhibited HIV-1 infection in HeLa-derived and primary CD4+ T-cells. Furthermore, the inhibition of endocytosis in HeLa-derived cells promoted hemifusion at the PM but abrogated complete fusion. Collectively, these data reveal that the primary HIV-1 entry pathway in diverse cell types is through fusion with pH-neutral intracellular vesicles.
尽管已经进行了广泛的研究,但 HIV-1 在不同靶细胞中的主要进入部位(质膜 [PM] 与内体)仍存在争议。为了描绘 HIV-1 融合的部位,我们采用了三重标记方法,该方法涉及用荧光蛋白 iCherry 标记假病毒的液相病毒内容物、DiD 标记病毒膜以及 ecliptic pHluorin 标记细胞外 pH 传感器。病毒内容物标记物 iCherry 在病毒-细胞融合时会释放到细胞质中,而与 PM(信号丢失)或内体膜(点状 DiD 外观无变化)融合的程度可区分病毒融合的主要部位。此外,整合到病毒膜中的 ecliptic pHluorin 报告病毒融合是否发生在酸性内体中。在活的 HeLa 衍生细胞、CD4+T 细胞系和激活的原代人 CD4+T 细胞中进行实时单病毒成像显示,HIV-1 强烈(80-90%)优先与内体融合。有趣的是,我们观察到 HIV-1 融合仅与 pH 中性的细胞内囊泡发生,而从不与酸化的内体发生。这些内体融合事件可能最终导致感染,因为内体融合抑制剂,如 EIPA、Pitstop2 和 Dynasore 以及显性失活的 dynamin-2 突变体,抑制了 HeLa 衍生细胞和原代 CD4+T 细胞中的 HIV-1 感染。此外,HeLa 衍生细胞中的内体摄取抑制剂促进了 PM 处的半融合,但阻断了完全融合。总之,这些数据表明,不同细胞类型中 HIV-1 的主要进入途径是通过与 pH 中性的细胞内囊泡融合。